- Home
- ARVN vs GRPN Comparison
ARVN vs GRPN Comparison
Compare ARVN & GRPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARVN | GRPN |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 806.0M | 723.4M |
| IPO Year | 2018 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ARVN | GRPN |
|---|---|---|
| Price | $12.16 | $18.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 4 |
| Target Price | $17.89 | ★ $31.25 |
| AVG Volume (30 Days) | ★ 1.0M | 940.9K |
| Earning Date | 02-10-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $312,300,000.00 | ★ $496,093,000.00 |
| Revenue This Year | $11.17 | $4.17 |
| Revenue Next Year | N/A | $10.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 93.86 | N/A |
| 52 Week Low | $5.90 | $9.21 |
| 52 Week High | $21.00 | $43.08 |
Technical Indicators
Market Signals| Indicator | ARVN | GRPN |
|---|---|---|
| Relative Strength Index (RSI) | 52.88 | 55.68 |
| Support Level | $11.86 | $15.50 |
| Resistance Level | $12.50 | $18.68 |
| Average True Range (ATR) | 0.53 | 0.75 |
| MACD | -0.12 | 0.32 |
| Stochastic Oscillator | 39.41 | 81.45 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About GRPN Groupon Inc.
Groupon Inc acts as the middleman between consumers and merchants, offering products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.